Alphatec (NSDQ:ATEC) said last week that it succeeded in raising $57.7 million in a stock offering for its line of spine implants. The Carlsbad, Calif.-based company had said it planned to float 10.9 million shares at $4.60 apiece, for gross proceeds of $50.1 million. That number rose to $57.7 million because the flotation’s underwriters fully […]
With 2014 a rebounding year for medical device and biopharmaceutical IPOs, 2015 should build further on that progress, a panel at the MedTech Investing Conference said this week.
August 19, 2014 by Arezu Sarvestani
ElectroCore said it tapped investment bank Piper Jaffray to help it court potential partners to commercialize the non-invasive vagus nerve stimulation treatment for headaches it’s developing.
The Danvers, Mass.-based medical device company’s stock fell from a $17.20-per-share close April 8 to end yesterday at $16.52 per share, a more than 3.9% decline. ABMD shares were trading at $16.98 apiece as of about 11 this morning, however, up 2.8%.
Analysts at a trio of investment advisory firms downgraded their estimates for C.R. Bard (NYSE:BCR) stock, which hasn’t fared well recently.